top of page
Writer's pictureIV Therapy Academy

IV Therapy for Crohn's Disease and Ulcerative Colitis Management

Updated: Sep 21

IV therapy has emerged as a crucial treatment option for patients suffering from Crohn's disease and ulcerative colitis, both of which are types of inflammatory bowel disease (IBD). It offers rapid symptom relief and effective support for patients with moderate to severe cases who may not respond to traditional treatments. By administering medications and nutrients directly into the bloodstream, IV therapy provides customized care tailored to individual needs, including hydration and nutritional support.


While generally safe, patients may experience some side effects, such as injection site discomfort or allergic reactions, which are monitored during treatment. Overall, IV therapy can significantly enhance the quality of life for those with these chronic conditions, making it important to consult healthcare providers for personalized treatment options.


Vitamin-C Infusions
IV Nutrition Therapy Delivers Vitamins and Nutrients Directly Into The Blood Stream

If you’re looking for the best balance between prescribing treatments for your Ulcerative Colitis or Crohn’s Disease patient, incorporating IV nutritional therapy into their treatment plan can help them achieve better health.


Let's find out more!


How Infusion Therapy Helps Treat Crohn’s Disease


Infusion therapy for Crohn's disease typically involves biologic medications, which are designed to target specific components of the immune system that contribute to inflammation in the gastrointestinal (GI) tract. Common biologics used in this treatment include:


  1. Infliximab (Remicade): An anti-TNF (tumor necrosis factor) therapy that helps reduce the inflammatory response by targeting and neutralizing TNF, a protein involved in systemic inflammation.

  2. Adalimumab (Humira): Another anti-TNF medication that works similarly to infliximab but is administered subcutaneously and can also be used in infusion therapy.

  3. Ustekinumab (Stelara): This biologic targets interleukin-12 and interleukin-23, proteins that play a role in immune response and inflammation, helping to manage Crohn's symptoms.

  4. Vedolizumab (Entyvio): A medication that targets a specific protein involved in the migration of white blood cells to the GI tract, thereby reducing inflammation and controlling disease activity.


The infusion process is typically conducted in outpatient settings such as infusion centers or hospitals. During the procedure, a healthcare professional inserts a thin tube (catheter) into a vein, usually in the arm, to deliver the medication over a period that can range from 30 minutes to several hours, depending on the prescribed dosage and medication.


Benefits of Infusion Therapy for Crohn’s Disease


Infusion therapy offers several advantages for Crohn's disease patients:


  1. Rapid Symptom Relief: Due to direct bloodstream administration, medications can act quickly, providing faster relief from symptoms such as abdominal pain, diarrhea, and fatigue compared to oral medications.

  2. Maintaining Remission: Regular infusions can help sustain remission, reducing the frequency and severity of flare-ups, and improving long-term disease management.

  3. Personalized Treatment: The therapy can be tailored to the patient’s specific needs, considering factors such as the severity of symptoms, previous treatment responses, and overall health.


Potential Side Effects and Risks


While generally safe, infusion therapy does carry some risks. Patients may experience:


  • Increased Risk of Infections: Since biologic medications suppress certain parts of the immune system, there is an elevated risk of infections such as tuberculosis and hepatitis B.

  • Allergic Reactions: Some patients may develop allergic reactions at the injection site or systemic reactions, which healthcare providers closely monitor during the infusion.

  • Other Side Effects: Common side effects may include headache, nausea, fatigue, and mild injection site discomfort.


How Infusion Therapy Helps Treat Ulcerative Colitis


Infusion therapy is a vital treatment option for patients with ulcerative colitis, particularly those with moderate to severe disease who have not responded adequately to oral medications. This therapy involves administering medications directly into the bloodstream, allowing rapid and targeted delivery to the inflamed areas of the gastrointestinal tract.


Biologic medications commonly used in infusion therapy include anti-TNFs (tumor necrosis factor inhibitors) like infliximab and adalimumab, which work by blocking the action of TNF, a protein that plays a key role in the inflammatory process.


Additionally, anti-integrins such as vedolizumab target specific adhesion receptors (integrins) on the surface of immune cells, preventing them from migrating to the gut and thereby reducing inflammation. Other biologics, like ustekinumab, target interleukin-12 and interleukin-23, which are also involved in the inflammatory response. This targeted approach helps to control symptoms more effectively than traditional treatments.



Benefits of Infusion Therapy for Ulcerative Colitis


Infusion therapy offers several significant benefits for patients with ulcerative colitis:


  • Rapid and Effective Relief: Many patients experience quick relief from symptoms, often during or shortly after the infusion. This is particularly important during flare-ups when symptoms can be debilitating.

  • Higher Rates of Remission: Clinical studies, including randomized controlled trials (RCTs), have demonstrated that biologic therapies can lead to higher rates of remission and endoscopic improvement compared to traditional oral medications. For example, the efficacy of infliximab and adalimumab has been well-documented in maintaining long-term remission.

  • Long-Term Management: Regular infusions can help maintain remission and prevent flare-ups, significantly improving the quality of life for patients. This long-term management is crucial for preventing complications associated with uncontrolled ulcerative colitis.

  • Personalized Treatment: Infusion therapy allows for a personalized approach, as healthcare providers can tailor the treatment plan based on the individual patient's disease characteristics, treatment history, and response to previous therapies.


Potential Side Effects and Risks


While infusion therapy is generally considered safe, it does carry some potential side effects and risks that patients should be aware of:


  • Injection Site Reactions: Patients may experience discomfort, swelling, or redness at the injection site. These reactions are usually mild and resolve quickly.

  • Allergic Responses: Some individuals may have allergic reactions to the medication, which can range from mild to severe. Symptoms may include hives, difficulty breathing, or swelling of the face and throat.

  • Increased Risk of Infections: Patients receiving immunosuppressive therapies are at a higher risk for infections, including serious conditions like latent tuberculosis (TB). Screening for TB and other infections is essential before starting therapy.

  • Severe Complications: In rare cases, severe complications such as toxic megacolon—a condition characterized by extreme dilation of the colon—can occur, particularly in patients with severe ulcerative colitis.


How Effective is IV Therapy in Preventing Crohn’s Disease Flare-ups?


IV therapy effectively prevents flare-ups in Crohn's disease by delivering targeted biologic medications directly into the bloodstream, reducing inflammation and maintaining remission. This approach allows for rapid response and customizable treatment plans tailored to individual patient needs.


How Long Does an IV Therapy Session for Crohn's Disease Typically Last?


IV therapy sessions for Crohn's disease typically last between 30 minutes to several hours, depending on the specific medication being administered. For instance, infusions of biologics like Stelara usually last at least an hour, while other treatments, such as IVIG, can take about 3 hours. Patients may also need additional time for preparation and monitoring after the infusion is complete.


IV Treatment Over Steroid Shots or Oral Medicine


IV treatment offers a viable alternative to steroid shots and oral medications for patients with ulcerative colitis and Crohn's disease, as these oral treatments often have limited effectiveness over time.


While self-administered steroid shots may not be suitable for everyone, intravenous options like Remicade have demonstrated success in treating these conditions, particularly when patients struggle to absorb oral medications. Patients can receive Remicade infusions in a more relaxed setting at local IV therapy clinics, avoiding the stress of hospital visits.


Additionally, IV nutritional therapy can benefit patients recovering from illness, managing flare-ups, or those who are pregnant. When considering treatment options, it's important to weigh IV therapy vs. oral supplements, as IV therapy can provide faster absorption and higher bioavailability of nutrients. It is crucial for patients to consult their healthcare providers before starting IV therapy and to understand that such treatments should complement, not replace, a healthy diet.



Final Thoughts on IV Therapy for IBD


IV therapy represents a vital component of the treatment landscape for Crohn's disease and ulcerative colitis. Providing targeted medication and nutritional support can significantly enhance the quality of life for patients struggling with these chronic conditions. If you or someone you know is considering IV therapy, it is essential to consult with a healthcare provider to determine the most appropriate treatment plan tailored to individual needs, including IV for irritable bowel syndrome.


To learn how to safely prescribe and administer IV Nutritional Therapy, please check out our Online IV Nutritional Therapy Course.

Blog Posts

bottom of page